Skip to content

Clinical trials

Phase 3 Peripheral Vascular Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Vascular Diseases Phase: Phase 3 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20032
20052
20061
20073
20081
20094
20101
20121
20191
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Northwestern University3
Abbott Medical Devices2
Tanabe Pharma Corporation2
ActivBiotics1
AtheroMed, Inc1
Boston Scientific Corporation1
Cogentus Pharmaceuticals1
Ethicon, Inc.1
Joselyn Cerezo, MD1
Kos Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Vascular Diseases21
Peripheral Arterial Disease10
Intermittent Claudication9
Atherosclerosis6
Chronic Limb-Threatening Ischemia3
Cardiovascular Diseases2
Mobility Limitation2
Acute Coronary Syndrome1
Cerebrovascular Disorders1
Coronary Artery Disease1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.